Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Cancers|March 14, 2026
Correction: Chang et al. Exercise Guidelines in Pancreatic Cancer Based on the Dietz Model. Cancers 2025, 17, 630Philip J Chang, Andrew E Hendifar, Gillian Gresham, et al.
Frontiers in Immunology|September 16, 2021
Multi-Epitope-Based Vaccines for Colon Cancer Treatment and PreventionLauren R Corulli, Denise L Cecil, Ekram Gad, et al.
Investigational New Drugs|March 20, 2016
A phase 1 clinical trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in patients with advanced pancreatic and gastric cancersAndrew L Coveler, Andrew H Ko, Daniel V T Catenacci, et al.
Breast Cancer Research and Treatment|February 1, 2008
Common adjuvant breast cancer therapies do not inhibit cancer vaccine induced T cell immunityAndrew L Coveler, Vivian Goodell, Devon J Webster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2023
A Phase I/II Trial of HER2 Vaccine-Primed Autologous T-Cell Infusions in Patients with Treatment Refractory HER2-Overexpressing Breast CancerMary L Disis, Yushe Dang, Andrew L Coveler, et al.
Abdominal Radiology (New York)|October 20, 2020
Feasibility of wide detector CT perfusion imaging performed during routine staging and restaging of pancreatic ductal adenocarcinomaRyan B O'Malley, Erik V Soloff, Andrew L Coveler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
Immunization with a Plasmid DNA Vaccine Encoding the N-Terminus of Insulin-like Growth Factor Binding Protein-2 in Advanced Ovarian Cancer Leads to High-level Type I Immune ResponsesDenise L Cecil, John B Liao, Yushe Dang, et al.
JAMA Oncology|January 24, 2017
Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases: A Phase 2 Clinical TrialLupe G Salazar, Hailing Lu, Jessica L Reichow, et al.
Cancer Immunology, Immunotherapy : CII|October 29, 2013
HER-2/neu vaccine-primed autologous T-cell infusions for the treatment of advanced stage HER-2/neu expressing cancersMary L Disis, Yushe Dang, Andrew L Coveler, et al.
Pageof 6